Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $13.71 in the last session, down -1.51% from day before closing price of $13.92. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.69 million shares were traded. MD stock price reached its highest trading level at $13.902 during the session, while it also had its lowest trading level at $13.53.
Ratios:
We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.82.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 21 ’25 when Swift James D bought 18,530 shares for $16.63 per share.
ORDAN MARK S sold 27,600 shares of MD for $423,660 on Nov 13 ’24. The Director now owns 138,683 shares after completing the transaction at $15.35 per share. On Nov 13 ’24, another insider, ORDAN MARK S, who serves as the Director of the company, bought 27,600 shares for $15.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1176723840 and an Enterprise Value of 1467274624. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.58 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 0.729 whereas that against EBITDA is 6.796.
Stock Price History:
The Beta on a monthly basis for MD is 1.35, which has changed by 0.44620252 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $17.67, while it has fallen to a 52-week low of $6.62. The 50-Day Moving Average of the stock is -2.95%, while the 200-Day Moving Average is calculated to be 16.97%.
Shares Statistics:
According to the various share statistics, MD traded on average about 674.51K shares per day over the past 3-months and 684160 shares per day over the past 10 days. A total of 85.87M shares are outstanding, with a floating share count of 84.66M. Insiders hold about 1.36% of the company’s shares, while institutions hold 98.29% stake in the company. Shares short for MD as of 1740700800 were 2772713 with a Short Ratio of 4.11, compared to 1738281600 on 2373565. Therefore, it implies a Short% of Shares Outstanding of 2772713 and a Short% of Float of 4.5600000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
